Asia-Pacific Hematological Disorders Market Outlook to 2036 - Hematology Tests and Hemostasis Tests

1.1 What Is This Report About?
1.2 Hematological Disorders Market Segmentation
1.3 Definitions of Markets Covered in the Report

2.1 Hematological Disorders Market, Asia-Pacific, Revenue ($m), 2024-2036
2.2 Hematological Disorders Market, Asia-Pacific, Revenue ($m), 2024-2036
2.3 Hematological Disorders Market, Asia-Pacific, Volume (Units), 2024-2036
2.4 Hematological Disorders Market, Asia-Pacific, Volume (Units), 2024-2036
2.5 Hematological Disorders Market, Asia-Pacific, Company Share by Revenue ($m), 2025

3.1 Hematological Disorders Market, Australia, Revenue ($m), 2024-2036
3.1.1 Hematology Tests Market, Australia, Revenue ($m), by Segment, 2024-2036
3.1.2 Hemostasis Tests Market, Australia, Revenue ($m), by Segment, 2024-2036
3.2 Hematological Disorders Market, Australia, Volume (Units), 2024-2036
3.2.1 Hematology Tests Market, Australia, Volume (Units), by Segment, 2024-2036
3.2.2 Hemostasis Tests Market, Australia, Volume (Units), by Segment, 2024-2036
3.3 Hematological Disorders Market, Australia, Average Price ($), 2024-2036
3.4 Hematological Disorders Market, Australia, Company Share by Revenue ($m), 2025

4.1 Hematological Disorders Market, China, Revenue ($m), 2024-2036
4.1.1 Hematology Tests Market, China, Revenue ($m), by Segment, 2024-2036
4.1.2 Hemostasis Tests Market, China, Revenue ($m), by Segment, 2024-2036
4.2 Hematological Disorders Market, China, Volume (Units), 2024-2036
4.2.1 Hematology Tests Market, China, Volume (Units), by Segment, 2024-2036
4.2.2 Hemostasis Tests Market, China, Volume (Units), by Segment, 2024-2036
4.3 Hematological Disorders Market, China, Average Price ($), 2024-2036
4.4 Hematological Disorders Market, China, Company Share by Revenue ($m), 2025

5.1 Hematological Disorders Market, India, Revenue ($m), 2024-2036
5.1.1 Hematology Tests Market, India, Revenue ($m), by Segment, 2024-2036
5.1.2 Hemostasis Tests Market, India, Revenue ($m), by Segment, 2024-2036
5.2 Hematological Disorders Market, India, Volume (Units), 2024-2036
5.2.1 Hematology Tests Market, India, Volume (Units), by Segment, 2024-2036
5.2.2 Hemostasis Tests Market, India, Volume (Units), by Segment, 2024-2036
5.3 Hematological Disorders Market, India, Average Price ($), 2024-2036
5.4 Hematological Disorders Market, India, Company Share by Revenue ($m), 2025

6.1 Hematological Disorders Market, Japan, Revenue ($m), 2024-2036
6.1.1 Hematology Tests Market, Japan, Revenue ($m), by Segment, 2024-2036
6.1.2 Hemostasis Tests Market, Japan, Revenue ($m), by Segment, 2024-2036
6.2 Hematological Disorders Market, Japan, Volume (Units), 2024-2036
6.2.1 Hematology Tests Market, Japan, Volume (Units), by Segment, 2024-2036
6.2.2 Hemostasis Tests Market, Japan, Volume (Units), by Segment, 2024-2036
6.3 Hematological Disorders Market, Japan, Average Price ($), 2024-2036
6.4 Hematological Disorders Market, Japan, Company Share by Revenue ($m), 2025

7.1 Hematological Disorders Market, South Korea, Revenue ($m), 2024-2036
7.1.1 Hematology Tests Market, South Korea, Revenue ($m), by Segment, 2024-2036
7.1.2 Hemostasis Tests Market, South Korea, Revenue ($m), by Segment, 2024-2036
7.2 Hematological Disorders Market, South Korea, Volume (Units), 2024-2036
7.2.1 Hematology Tests Market, South Korea, Volume (Units), by Segment, 2024-2036
7.2.2 Hemostasis Tests Market, South Korea, Volume (Units), by Segment, 2024-2036
7.3 Hematological Disorders Market, South Korea, Average Price ($), 2024-2036
7.4 Hematological Disorders Market, South Korea, Company Share by Revenue ($m), 2025

8.1 Hematological Disorders Market Pipeline Products
8.2 Hematological Disorders - Pipeline Products by Stage of Development
8.3 Hematological Disorders - Pipeline Products by Segment
8.4 Hematological Disorders - Pipeline Products by Territory
8.5 Hematological Disorders - Pipeline Products by Regulatory Path
8.6 Hematological Disorders - Pipeline Products by Estimated Approval Date

9.1 Sysmex Corp
9.1.1 Company Overview
9.2 Roche Diagnostics International Ltd
9.2.1 Company Overview
9.3 Siemens AG
9.3.1 Company Overview
9.4 Horiba Ltd
9.4.1 Company Overview
9.5 Abbott Laboratories
9.5.1 Company Overview
9.6 Instrumentation Laboratory Co
9.6.1 Company Overview
9.7 Diagnostica Stago SAS
9.7.1 Company Overview

10.1 Corporate Communications
10.1.1 Nov 13, 2025: Cleveland Clinic Pitch Competition Awards $100,000 Grant to AutoCMR Inventors
10.1.2 Nov 06, 2025: TEDCO Signs Agreement for Up to $50 Million Investment with TAIIDA and SFIC Group
10.1.3 Oct 29, 2025: Regenerative Medicine Also Known As Stem Cell Therapy
10.1.4 Sep 26, 2025: Next Gen Lab Tech, Mini CT Scanners, And AI Diagnostics Receive Grant Funding
10.1.5 Sep 11, 2025: Navignostics Chosen as Finalist for 2025 Swiss Technology Award
10.2 Other Significant Developments
10.2.1 Nov 13, 2025: Cleveland Clinic Pitch Competition Awards $100,000 Grant to AutoCMR Inventors
10.2.2 Nov 12, 2025: Bionexus Gene Lab Corp. Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization
10.2.3 Nov 05, 2025: YD Bio and EG BioMed Expand U.S. Access to OkaiDx for Breast Cancer Monitoring
10.2.4 Sep 26, 2025: Next Gen Lab Tech, Mini CT Scanners, And AI Diagnostics Receive Grant Funding
10.3 Product News
10.3.1 Dec 19, 2025: Weiguang Biotech made a brilliant appearance at the 2025 Shenzhen International High-Performance Medical Device Exhibition
10.3.2 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV
10.3.3 Nov 17, 2025: ScreenCell Standardizes CTC Isolation Kits to Two Filtration Units
10.3.4 Nov 11, 2025: Samsung Active Asset Management Launches KoAct US Biohealthcare Active ETF Benchmarking the Solactive US Biohealthcare Index
10.3.5 Nov 05, 2025: YD Bio and EG BioMed Expand U.S. Access to OkaiDx for Breast Cancer Monitoring
10.3.6 Sep 09, 2025: Detects Even Minute Amounts of Toxins… Early Diagnosis Technology for ‘Hemolytic Uremic Syndrome’ Developed Using Ultra-Sensitive Graphene
10.4 Research And Development
10.4.1 Feb 04, 2026: Advancing Early Detection for Kidney Disease in Sickle Cell
10.5 Strategy And Business Planning
10.5.1 Nov 13, 2025: Teijin And URAT Partner To Expand Regenerative Medicine And Implantable Medical Devices In Japan And India
10.5.2 Nov 12, 2025: Bionexus Gene Lab Corp. Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization
10.5.3 Nov 11, 2025: Samsung Active Asset Management Launches KoAct US Biohealthcare Active ETF Benchmarking the Solactive US Biohealthcare Index
10.5.4 Nov 06, 2025: TEDCO Signs Agreement for Up to $50 Million Investment with TAIIDA and SFIC Group
10.5.5 Oct 22, 2025: HMI Medical Expands Imaging Services in Singapore

11.1 Research Methodology
11.1.1 Coverage
11.1.2 Secondary Research
11.1.3 Primary Research
11.1.4 Market Modeling and Forecasting
11.1.5 Company Share Analysis
11.1.6 Benchmarking
11.2 the Analyst Consulting
11.3 Contact Us
11.4 Disclaimer

Table 1: Hematological Disorders Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2024-2036
Table 2: Hematological Disorders Market, Asia-Pacific, Revenue ($m), USD Constant, 2024-2036
Table 3: Hematological Disorders Market, Asia-Pacific, Volume (Units), 2024-2036
Table 4: Hematological Disorders Market, Asia-Pacific, Volume (Units), 2024-2036
Table 5: Hematological Disorders Market, Asia-Pacific, Company Share by Revenue ($m), 2025
Table 6: Hematological Disorders Market, Australia, Revenue ($m), USD Constant, 2024-2036
Table 7: Hematology Tests Market, Australia, Revenue ($m), USD Constant, 2024-2036
Table 8: Hemostasis Tests Market, Australia, Revenue ($m), USD Constant, 2024-2036
Table 9: Hematological Disorders Market, Australia, Volume (Units), 2024-2036
Table 10: Hematology Tests Market, Australia, Volume (Units), 2024-2036
Table 11: Hemostasis Tests Market, Australia, Volume (Units), 2024-2036
Table 12: Hematological Disorders Market, Australia, Average Price ($), 2024-2036
Table 13: Hematological Disorders Market, Australia, Company Share by Revenue ($m), USD Constant, 2025
Table 14: Hematological Disorders Market, China, Revenue ($m), USD Constant, 2024-2036
Table 15: Hematology Tests Market, China, Revenue ($m), USD Constant, 2024-2036
Table 16: Hemostasis Tests Market, China, Revenue ($m), USD Constant, 2024-2036
Table 17: Hematological Disorders Market, China, Volume (Units), 2024-2036
Table 18: Hematology Tests Market, China, Volume (Units), 2024-2036
Table 19: Hemostasis Tests Market, China, Volume (Units), 2024-2036
Table 20: Hematological Disorders Market, China, Average Price ($), 2024-2036
Table 21: Hematological Disorders Market, China, Company Share by Revenue ($m), USD Constant, 2025
Table 22: Hematological Disorders Market, India, Revenue ($m), USD Constant, 2024-2036
Table 23: Hematology Tests Market, India, Revenue ($m), USD Constant, 2024-2036
Table 24: Hemostasis Tests Market, India, Revenue ($m), USD Constant, 2024-2036
Table 25: Hematological Disorders Market, India, Volume (Units), 2024-2036
Table 26: Hematology Tests Market, India, Volume (Units), 2024-2036
Table 27: Hemostasis Tests Market, India, Volume (Units), 2024-2036
Table 28: Hematological Disorders Market, India, Average Price ($), 2024-2036
Table 29: Hematological Disorders Market, India, Company Share by Revenue ($m), USD Constant, 2025
Table 30: Hematological Disorders Market, Japan, Revenue ($m), USD Constant, 2024-2036
Table 31: Hematology Tests Market, Japan, Revenue ($m), USD Constant, 2024-2036
Table 32: Hemostasis Tests Market, Japan, Revenue ($m), USD Constant, 2024-2036
Table 33: Hematological Disorders Market, Japan, Volume (Units), 2024-2036
Table 34: Hematology Tests Market, Japan, Volume (Units), 2024-2036
Table 35: Hemostasis Tests Market, Japan, Volume (Units), 2024-2036
Table 36: Hematological Disorders Market, Japan, Average Price ($), 2024-2036
Table 37: Hematological Disorders Market, Japan, Company Share by Revenue ($m), USD Constant, 2025
Table 38: Hematological Disorders Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Table 39: Hematology Tests Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Table 40: Hemostasis Tests Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Table 41: Hematological Disorders Market, South Korea, Volume (Units), 2024-2036
Table 42: Hematology Tests Market, South Korea, Volume (Units), 2024-2036
Table 43: Hemostasis Tests Market, South Korea, Volume (Units), 2024-2036
Table 44: Hematological Disorders Market, South Korea, Average Price ($), 2024-2036
Table 45: Hematological Disorders Market, South Korea, Company Share by Revenue ($m), USD Constant, 2025
Table 46: Hematological Disorders Market Pipeline Products
Table 47: Hematological Disorders - Pipeline Products by Stage of Development
Table 48: Hematological Disorders Companies - Pipeline Products by Stage of Development
Table 49: Hematological Disorders - Pipeline Products by Segment
Table 50: Hematological Disorders - Pipeline Products by Territory
Table 51: Hematological Disorders - Pipeline Products by Regulatory Path
Table 52: Hematological Disorders - Pipeline Products by Estimated Approval Date
Table 53: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country

Figure 1: Hematological Disorders Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2024-2036
Figure 2: Hematological Disorders Market, Asia-Pacific, Revenue ($m), USD Constant, 2024-2036
Figure 3: Hematological Disorders Market, Asia-Pacific, Volume (Units), 2024-2036
Figure 4: Hematological Disorders Market, Asia-Pacific, Volume (Units), 2024-2036
Figure 5: Hematological Disorders Market, Asia-Pacific, Company Share (%), 2025
Figure 6: Hematological Disorders Market, Australia, Revenue ($m), USD Constant, 2024-2036
Figure 7: Hematology Tests Market, Australia, Revenue ($m), USD Constant, 2024-2036
Figure 8: Hemostasis Tests Market, Australia, Revenue ($m), USD Constant, 2024-2036
Figure 9: Hematological Disorders Market, Australia, Volume (Units), 2024-2036
Figure 10: Hematology Tests Market, Australia, Volume (Units), 2024-2036
Figure 11: Hemostasis Tests Market, Australia, Volume (Units), 2024-2036
Figure 12: Hematological Disorders Market, Australia, Company Share (%), 2025
Figure 13: Hematological Disorders Market, China, Revenue ($m), USD Constant, 2024-2036
Figure 14: Hematology Tests Market, China, Revenue ($m), USD Constant, 2024-2036
Figure 15: Hemostasis Tests Market, China, Revenue ($m), USD Constant, 2024-2036
Figure 16: Hematological Disorders Market, China, Volume (Units), 2024-2036
Figure 17: Hematology Tests Market, China, Volume (Units), 2024-2036
Figure 18: Hemostasis Tests Market, China, Volume (Units), 2024-2036
Figure 19: Hematological Disorders Market, China, Company Share (%), 2025
Figure 20: Hematological Disorders Market, India, Revenue ($m), USD Constant, 2024-2036
Figure 21: Hematology Tests Market, India, Revenue ($m), USD Constant, 2024-2036
Figure 22: Hemostasis Tests Market, India, Revenue ($m), USD Constant, 2024-2036
Figure 23: Hematological Disorders Market, India, Volume (Units), 2024-2036
Figure 24: Hematology Tests Market, India, Volume (Units), 2024-2036
Figure 25: Hemostasis Tests Market, India, Volume (Units), 2024-2036
Figure 26: Hematological Disorders Market, India, Company Share (%), 2025
Figure 27: Hematological Disorders Market, Japan, Revenue ($m), USD Constant, 2024-2036
Figure 28: Hematology Tests Market, Japan, Revenue ($m), USD Constant, 2024-2036
Figure 29: Hemostasis Tests Market, Japan, Revenue ($m), USD Constant, 2024-2036
Figure 30: Hematological Disorders Market, Japan, Volume (Units), 2024-2036
Figure 31: Hematology Tests Market, Japan, Volume (Units), 2024-2036
Figure 32: Hemostasis Tests Market, Japan, Volume (Units), 2024-2036
Figure 33: Hematological Disorders Market, Japan, Company Share (%), 2025
Figure 34: Hematological Disorders Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Figure 35: Hematology Tests Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Figure 36: Hemostasis Tests Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Figure 37: Hematological Disorders Market, South Korea, Volume (Units), 2024-2036
Figure 38: Hematology Tests Market, South Korea, Volume (Units), 2024-2036
Figure 39: Hemostasis Tests Market, South Korea, Volume (Units), 2024-2036
Figure 40: Hematological Disorders Market, South Korea, Company Share (%), 2025
Figure 41: Hematological Disorders - Pipeline Products by Stage of Development
Figure 42: Hematological Disorders - Pipeline Products by Segment
Figure 43: Hematological Disorders - Pipeline Products by Territory
Figure 44: Hematological Disorders - Pipeline Products by Regulatory Path
Figure 45: Hematological Disorders - Pipeline Products by Estimated Approval Date